Optipharm (153710)

KOSDAQ · 4,745 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

4,5005,0005,5006,000 H 6,200L 4,260 25.0826.0526.08
Mkt Cap
69.6B
PBR
2.74
52W
4K~6K

Optipharm operates in the Pharmaceuticals sector.

Legal name: Optipharm.CO.,LTD

As of the Aug 26, 2026 close, the market capitalization was 69.6 billion KRW, with a P/B of 2.74.

These figures can be verified in the DART filing (receipt no. 20260313000903).

Checks

1 applicable out of 8 items

Check details →

Recent Filings

Semi-Annual Report (2026.06)

Corporate Briefing (IR)

All filings →

Checks

1 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: No convertible bonds outstanding.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-14Semi-Annual Report (2026.06)
2026-08-12Corporate Briefing (IR)